Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans
Background: The gut microbiota and its metabolites are essential for host health and dysbiosis has been involved in several pathologic conditions such as type 2 diabetes (T2D) and cardiovascular disease (CVD). Recent studies have identified that plasma imidazole propionate (ImP), a microbial-produce...
Main Authors: | Jamie van Son, Mireille J. Serlie, Marcus Ståhlman, Fredrik Bäckhed, Max Nieuwdorp, Judith Aron-Wisnewsky |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/8/2706 |
Similar Items
-
The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans
by: Kasper W. ter Horst, et al.
Published: (2017-11-01) -
When MINMOD Artifactually Interprets Strong Insulin Secretion as Weak Insulin Action
by: Joon Ha, et al.
Published: (2021-04-01) -
Adropin reduces blood glucose levels in mice by limiting hepatic glucose production
by: Dharendra Thapa, et al.
Published: (2019-04-01) -
Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes
by: Motonori Sato, et al.
Published: (2021-09-01) -
Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clamp method on healthy volonters
by: Alexander Y. Mayorov, et al.
Published: (2018-12-01)